Practical Clinical Application of Biochemical Markers of Bone Turnover
- 1 September 1999
- journal article
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 2 (3) , 323-342
- https://doi.org/10.1385/jcd:2:3:323
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral densityArchives of internal medicine (1960), 1997
- Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal womenJournal of Bone and Mineral Research, 1996
- A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal womenJournal of Bone and Mineral Research, 1996
- Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacyBone, 1996
- Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosisBone, 1996
- Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapyOsteoporosis International, 1995
- Quality control of DXA instruments in multicenter trialsOsteoporosis International, 1995
- Effect of hormone replacement therapy on bone and lipid metabolism in women oophorectomized for the treatment of gynecologic malignanciesInternational Journal of Gynecology & Obstetrics, 1994
- Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitroJournal of Bone and Mineral Research, 1994
- Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosisJournal of Bone and Mineral Research, 1993